Quarterly report pursuant to Section 13 or 15(d)

Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statement of Cash Flows (Detail)

v3.10.0.1
Parent, Guarantor, Non-Guarantor Unaudited Consolidating Condensed Financial Statements - Consolidated Condensed Statement of Cash Flows (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:        
Net income (loss) $ (22,877) $ (29,888) $ (51,673) $ (69,697)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 27,136 30,982 55,685 63,184
(Gain) loss on disposition of assets, net     135 465
Deferred tax expense (benefit)     (896) (934)
Expenses not requiring cash     4,030 4,948
Equity in net earnings of subsidiaries 0 0 0 0
Change in assets and liabilities:        
Accounts and notes receivable     (392) (6,853)
Other assets     8,112 (1,722)
Accounts payable and accrued liabilities     (6,026) (8,235)
Accrued income taxes     (944) 1,276
Net cash provided by (used in) operating activities     8,031 (17,568)
Cash flows from investing activities:        
Capital expenditures     (32,549) (26,559)
Proceeds from the sale of assets     851 185
Net cash provided by (used in) investing activities     (31,698) (26,374)
Cash flows from financing activities:        
Payments of debt issuance costs     (1,440) 0
Convertible preferred stock dividend     (1,813) (1,239)
Shares surrendered in lieu of tax     (170) (612)
Proceeds from the issuance of common stock     0 25,200
Proceeds from the issuance of convertible preferred stock     0 50,000
Payment of equity issuance costs     0 (2,864)
Intercompany advances, net       0
Net cash provided by (used in) financing activities     (3,423) 70,485
Net increase (decrease) in cash and cash equivalents     (27,090) 26,543
Cash and cash equivalents at beginning of period     141,549 119,691
Cash and cash equivalents at end of period 114,459 146,234 114,459 146,234
Reportable Legal Entities | Parent        
Cash flows from operating activities:        
Net income (loss) (22,877) (29,888) (51,673) (69,696)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 0 0 0 0
(Gain) loss on disposition of assets, net     0 0
Deferred tax expense (benefit)     (6,782) (10,359)
Expenses not requiring cash     2,681 3,154
Equity in net earnings of subsidiaries 11,079 15,823 27,451 37,602
Change in assets and liabilities:        
Accounts and notes receivable     0 0
Other assets     32,403 (50,315)
Accounts payable and accrued liabilities     (8,596) (37,753)
Accrued income taxes     6,810 71,942
Net cash provided by (used in) operating activities     (25,157) (55,425)
Cash flows from investing activities:        
Capital expenditures     0 0
Proceeds from the sale of assets     0 0
Net cash provided by (used in) investing activities     0 0
Cash flows from financing activities:        
Payments of debt issuance costs     (1,440)  
Convertible preferred stock dividend     (1,813) (1,239)
Shares surrendered in lieu of tax     (170) (612)
Proceeds from the issuance of common stock       25,200
Proceeds from the issuance of convertible preferred stock       50,000
Payment of equity issuance costs       (2,864)
Intercompany advances, net       8,946
Net cash provided by (used in) financing activities     (3,423) 79,431
Net increase (decrease) in cash and cash equivalents     (28,580) 24,006
Cash and cash equivalents at beginning of period     75,342 65,000
Cash and cash equivalents at end of period 46,762 89,006 46,762 89,006
Reportable Legal Entities | Guarantor        
Cash flows from operating activities:        
Net income (loss) (3,069) (8,698) (12,188) (24,287)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 19,488 20,270 39,484 41,458
(Gain) loss on disposition of assets, net     53 242
Deferred tax expense (benefit)     6,354 8,943
Expenses not requiring cash     561 120
Equity in net earnings of subsidiaries 0 0 0 0
Change in assets and liabilities:        
Accounts and notes receivable     (6,507) (13,787)
Other assets     (22,769) 32,013
Accounts payable and accrued liabilities     25,823 29,831
Accrued income taxes     (5,968) (54,000)
Net cash provided by (used in) operating activities     24,843 20,533
Cash flows from investing activities:        
Capital expenditures     (29,342) (18,726)
Proceeds from the sale of assets     67 25
Net cash provided by (used in) investing activities     (29,275) (18,701)
Cash flows from financing activities:        
Payments of debt issuance costs     0  
Convertible preferred stock dividend     0 0
Shares surrendered in lieu of tax     0 0
Proceeds from the issuance of common stock       0
Proceeds from the issuance of convertible preferred stock       0
Payment of equity issuance costs       0
Intercompany advances, net       361
Net cash provided by (used in) financing activities     0 361
Net increase (decrease) in cash and cash equivalents     (4,432) 2,193
Cash and cash equivalents at beginning of period     20,655 14,365
Cash and cash equivalents at end of period 16,223 16,558 16,223 16,558
Reportable Legal Entities | Non-Guarantor        
Cash flows from operating activities:        
Net income (loss) (8,010) (7,125) (15,263) (13,316)
Adjustments to reconcile net income (loss)        
Depreciation and amortization 7,648 10,712 16,201 21,726
(Gain) loss on disposition of assets, net     82 223
Deferred tax expense (benefit)     (468) 482
Expenses not requiring cash     (8,472) 1,674
Equity in net earnings of subsidiaries 0 0 0 0
Change in assets and liabilities:        
Accounts and notes receivable     6,115 6,934
Other assets     (136,289) 16,580
Accounts payable and accrued liabilities     148,225 (313)
Accrued income taxes     (1,786) (16,666)
Net cash provided by (used in) operating activities     8,345 17,324
Cash flows from investing activities:        
Capital expenditures     (3,207) (7,833)
Proceeds from the sale of assets     784 160
Net cash provided by (used in) investing activities     (2,423) (7,673)
Cash flows from financing activities:        
Payments of debt issuance costs     0  
Convertible preferred stock dividend     0 0
Shares surrendered in lieu of tax     0 0
Proceeds from the issuance of common stock       0
Proceeds from the issuance of convertible preferred stock       0
Payment of equity issuance costs       0
Intercompany advances, net       (9,307)
Net cash provided by (used in) financing activities     0 (9,307)
Net increase (decrease) in cash and cash equivalents     5,922 344
Cash and cash equivalents at beginning of period     45,552 40,326
Cash and cash equivalents at end of period 51,474 40,670 51,474 40,670
Eliminations        
Cash flows from operating activities:        
Net income (loss) 11,079 15,823 27,451 37,602
Adjustments to reconcile net income (loss)        
Depreciation and amortization 0 0 0 0
(Gain) loss on disposition of assets, net     0 0
Deferred tax expense (benefit)     0 0
Expenses not requiring cash     9,260 0
Equity in net earnings of subsidiaries (11,079) (15,823) (27,451) (37,602)
Change in assets and liabilities:        
Accounts and notes receivable     0 0
Other assets     134,767 0
Accounts payable and accrued liabilities     (171,478) 0
Accrued income taxes     0 0
Net cash provided by (used in) operating activities     0 0
Cash flows from investing activities:        
Capital expenditures     0 0
Proceeds from the sale of assets     0 0
Net cash provided by (used in) investing activities     0 0
Cash flows from financing activities:        
Payments of debt issuance costs     0  
Convertible preferred stock dividend     0 0
Shares surrendered in lieu of tax     0 0
Proceeds from the issuance of common stock       0
Proceeds from the issuance of convertible preferred stock       0
Payment of equity issuance costs       0
Intercompany advances, net       0
Net cash provided by (used in) financing activities     0 0
Net increase (decrease) in cash and cash equivalents     0 0
Cash and cash equivalents at beginning of period     0 0
Cash and cash equivalents at end of period $ 0 $ 0 $ 0 $ 0